BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 34215202)

  • 1. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis.
    Han Y; Jin L; Wang L; Wei L; Tu C
    Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study.
    Gholaminejad A; Roointan A; Gheisari Y
    BMC Immunol; 2021 Dec; 22(1):73. PubMed ID: 34861820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrative in silico Study to Discover Key Drivers in Pathogenicity of Focal and Segmental Glomerulosclerosis.
    Gholaminejad A; Ghaeidamini M; Simal-Gandara J; Roointan A
    Kidney Blood Press Res; 2022; 47(6):410-422. PubMed ID: 35306494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy.
    Feng S; Gao Y; Yin D; Lv L; Wen Y; Li Z; Wang B; Wu M; Liu B
    Kidney Blood Press Res; 2021; 46(3):275-285. PubMed ID: 33887734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network.
    Yang H; Zhang X; Xin G
    Ren Fail; 2018 Nov; 40(1):136-145. PubMed ID: 29532746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.
    Li B; Zhao X; Xie W; Hong Z; Cao Y; Zhang Y; Ding Y
    BMC Med Genomics; 2024 May; 17(1):134. PubMed ID: 38764052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
    Nie H; Yang H; Cheng L; Yu J
    J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
    Hu Y; Yu Y; Dong H; Jiang W
    PeerJ; 2023; 11():e15437. PubMed ID: 37250717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
    Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
    J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
    Ming J; Sana SRGL; Deng X
    Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Genes Involved in Diabetic Nephropathy Investigated by Microarray Analysis.
    Liu X; Li X
    J Comput Biol; 2019 Dec; 26(12):1438-1447. PubMed ID: 31356112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
    Chen S; Chen L; Jiang H
    Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of weighted gene co-expression network analysis to identify novel key genes in diabetic nephropathy.
    Wang Z; Chen X; Li C; Tang W
    J Diabetes Investig; 2022 Jan; 13(1):112-124. PubMed ID: 34245661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
    Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
    J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
    Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
    ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.